Short DAPT for High Bleeding Risk Has Stent Options

]]>(MedPage Today) -- A durable-polymer stent plus short-duration dual antiplatelet therapy (DAPT) was a safe and effective strategy in patients with high bleeding risk, researchers showed in the randomized ONYX ONE trial.Polymer-based zotarolimus...